The GLP-1 receptor signaling pathway begins when a GLP-1 agonist binds to its GPCR, triggering multiple mechanisms: This diversity of signaling has opened the door to drug design strategies based on biased agonism
You fill in a quick form, it arrives in the post, and you're on your own
Your GP can assess whether dose adjustment is appropriate (Wegovy is titrated from 0.25mg to a maintenance dose of 2.4mg weekly, or 1.7mg if the higher dose is not tolerated) or whether additional support such as referral to a dietitian or psychological services would be beneficial
A 10mg dose requires 0.59mL
Get Help Understanding Your GLP-1 Side Effects GLP-1 symptoms can change from the first week through later treatment, especially around medication adjustments
Ask for Specific Clinical Tests: Ask your GP to physically check for the "cuffing sign" at your ankles or wrists (where the fat stops abruptly, leaving the hands and feet "spared") and to look for the characteristic fat pads on the inner sides of your knees